Abstract
Background Relationships between low estimated glomerular filtration rate (eGFR) and albuminuria with poorer cognitive performance in patients with ischemic stroke are less clear. Our aim was to retrospectively ascertain the associations between these renal measures and cognitive performance in patients with ischemic stroke.
Methods Retrospective analysis was performed on 608 patients with acute ischemic stroke. Urine albumin-creatinine ratio (UACR) and eGFR were obtained from inpatient medical records. Global cognitive function via mini-mental state exam (MMSE) and Montreal Cognitive Assessment (MoCA) was determined one month after hospital discharge. The relationship between renal measures and cognitive performance was assessed using univariate and multiple linear regression analyses.
Results Patients had an average age of 66.6±4.1 years, and 48% were females. Average eGFR and UACR were 88.4±12.9 ml/min/1.73m2 and 83.6±314.2 mg/g, respectively. The number of patients with an eGFR of ≥90, 60 to 89, and <60 ml/min/1.73 m2 were (371, 61%), (207, 34%) and (30, 5%) respectively. The proportions with a UACR <30 mg/g, 30-300mg/g and >300 mg/g were 56%, 39% and 5%. Multivariate adjusted models showed that eGFR was independently associated with MMSE (β= –0.4; 95% CI= –0.5,-0.4; p <0.001) and MoCA (β = –0.6; 95% CI= –0.7,-0.5; p <0.001). However, the correlations between UACR and MMSE and MoCA were statistically non-significant.
Conclusion In patients with ischemic stroke, reduced eGFR but not albuminuria was associated with lower cognitive performance. These results show that the eGFR decline could be an effective indicator of cognitive impairment after a stroke. Therefore, regular monitoring and early detection of mild renal dysfunction in patients with acute ischemic stroke might be needed.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Ethics Committee of the Second Hospital of Shanxi Medical University (NO. 2019YX214?. The research was completed in accordance with Helsinki Declaration. Due to the retrospective nature of the study, informed consent of the patients was not required.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Not Applicable
Data Availability
Data are available from the Department of Neurology, Second Hospital, Shanxi Medical University (contact via Chunyan Zhang) for researchers who meet the criteria for access to confidential data.
